Chong Sun1, Bin Wang2, Jianmin Li3, Junjie Shangguan2, Matteo Figini2, Kang Zhou2, Liang Pan2, Quanhong Ma2, Zhuoli Zhang2,4. 1. Department of Orthopedics, The Affiliated Hospital of Qingdao University Qingdao, Shandong, China. 2. Department of Radiology, Feinberg School of Medicine, Northwestern University Chicago, IL, USA. 3. Department of Orthopedics, Qilu Hospital, Shandong University Jinan, Shandong, China. 4. Robert H. Lurie Comprehensive Cancer Center Chicago, IL, USA.
Abstract
BACKGROUND: Previous studies have shown the poor prognosis of metastatic breast cancer including bone metastasis. The early prediction and intervention of invasive breast carcinoma with bone metastasis are crucial to the outcomes of patients. The purpose of our study is to test the hypothesis that the collagen deposition of primary breast cancer can be used as a quantitative biomarker for the early prediction of bone metastasis. METHODS: A total of sixty breast cancer patients were included in our study, and the surgical specimens of these patients were divided into three groups: patients with no metastasis (group 1), lymph node metastasis (group 2), and bone metastasis (group 3). Masson's trichrome staining and hematoxylin and eosin staining were applied to all primary breast cancers. Collagen area percentage and tumor cell measurement of each sample were measured by HistoQuest software. RESULTS: Measurement results of collagen area percentage (%) in primary breast tumors were 32.39 ± 13.30, 25.37 ± 11.10, and 22.71 ± 8.91 for groups 1, 2, and 3, respectively. The corresponding P values were 0.0779 (group 1 vs. group 2), 0.4086 (group 2 vs. group 3), and 0.0102 (group 1 vs. group 3). The correlation between collagen area percentage and tumor cell measurement were group 1 (P = 0.5927, r = -0.1273), group 2 (P = 0.5711, r = -0.1348), and group 3 (P = 0.0003, r = -0.7253). CONCLUSIONS: The collagen deposition of primary breast cancer can be used as a quantitative biomarker for the early prediction of bone metastasis.
BACKGROUND: Previous studies have shown the poor prognosis of metastatic breast cancer including bone metastasis. The early prediction and intervention of invasive breast carcinoma with bone metastasis are crucial to the outcomes of patients. The purpose of our study is to test the hypothesis that the collagen deposition of primary breast cancer can be used as a quantitative biomarker for the early prediction of bone metastasis. METHODS: A total of sixty breast cancerpatients were included in our study, and the surgical specimens of these patients were divided into three groups: patients with no metastasis (group 1), lymph node metastasis (group 2), and bone metastasis (group 3). Masson's trichrome staining and hematoxylin and eosin staining were applied to all primary breast cancers. Collagen area percentage and tumor cell measurement of each sample were measured by HistoQuest software. RESULTS: Measurement results of collagen area percentage (%) in primary breast tumors were 32.39 ± 13.30, 25.37 ± 11.10, and 22.71 ± 8.91 for groups 1, 2, and 3, respectively. The corresponding P values were 0.0779 (group 1 vs. group 2), 0.4086 (group 2 vs. group 3), and 0.0102 (group 1 vs. group 3). The correlation between collagen area percentage and tumor cell measurement were group 1 (P = 0.5927, r = -0.1273), group 2 (P = 0.5711, r = -0.1348), and group 3 (P = 0.0003, r = -0.7253). CONCLUSIONS: The collagen deposition of primary breast cancer can be used as a quantitative biomarker for the early prediction of bone metastasis.
Entities:
Keywords:
Invasive breast carcinoma; bone metastasis; collagen deposition; early prediction
Authors: Alexander Liede; Katarzyna J Jerzak; Rohini K Hernandez; Sally W Wade; Ping Sun; Steven A Narod Journal: Breast Cancer Res Treat Date: 2016-04-15 Impact factor: 4.872
Authors: Anders Brabrand; Ian I Kariuki; Monica J Engstrøm; Olav A Haugen; Linda A Dyrnes; Bjørn O Åsvold; Magnus B Lilledahl; Anna M Bofin Journal: APMIS Date: 2014-08-06 Impact factor: 3.205
Authors: I Acerbi; L Cassereau; I Dean; Q Shi; A Au; C Park; Y Y Chen; J Liphardt; E S Hwang; V M Weaver Journal: Integr Biol (Camb) Date: 2015-05-11 Impact factor: 2.192
Authors: Anca Haisan; Radu Rogojanu; Camelia Croitoru; Daniela Jitaru; Cristina Tarniceriu; Mihai Danciu; Eugen Carasevici Journal: Biomed Res Int Date: 2013-09-01 Impact factor: 3.411